People's United Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.08M | Sell |
35,064
-1,341
| -4% | -$116K | 0.09% | 172 |
|
|
2021
Q4 | $3.18M | Sell |
36,405
-11,551
| -24% | -$959K | 0.08% | 183 |
|
|
2021
Q3 | $3.92M | Buy |
47,956
+2,936
| +7% | +$264K | 0.09% | 179 |
|
|
2021
Q2 | $4.11M | Sell |
45,020
-1,482
| -3% | -$132K | 0.09% | 174 |
|
|
2021
Q1 | $3.98M | Buy |
46,502
+2,315
| +5% | +$208K | 0.09% | 172 |
|
|
2020
Q4 | $4.17M | Sell |
44,187
-5,165
| -10% | -$451K | 0.1% | 155 |
|
|
2020
Q3 | $4.29M | Sell |
49,352
-1,322
| -3% | -$115K | 0.12% | 140 |
|
|
2020
Q2 | $4.43M | Sell |
50,674
-2,191
| -4% | -$189K | 0.13% | 137 |
|
|
2020
Q1 | $4.36M | Sell |
52,865
-297
| -0.6% | -$26.5K | 0.15% | 125 |
|
|
2019
Q4 | $5.03M | Sell |
53,162
-2,599
| -5% | -$233K | 0.14% | 136 |
|
|
2019
Q3 | $4.85M | Sell |
55,761
-4,636
| -8% | -$416K | 0.14% | 134 |
|
|
2019
Q2 | $5.51M | Sell |
60,397
-22,595
| -27% | -$1.91M | 0.15% | 133 |
|
|
2019
Q1 | $7.14M | Sell |
82,992
-24,250
| -23% | -$1.95M | 0.22% | 101 |
|
|
2018
Q4 | $8.25M | Sell |
107,242
-81,390
| -43% | -$6.34M | 0.29% | 82 |
|
|
2018
Q3 | $14.6M | Sell |
188,632
-2,447
| -1% | -$181K | 0.45% | 50 |
|
|
2018
Q2 | $12.9M | Sell |
191,079
-248
| -0.1% | -$17.1K | 0.33% | 91 |
|
|
2018
Q1 | $13.9M | Buy |
191,327
+4,988
| +3% | +$380K | 0.44% | 58 |
|
|
2017
Q4 | $14M | Sell |
186,339
-2,682
| -1% | -$202K | 0.44% | 61 |
|
|
2017
Q3 | $14.5M | Buy |
189,021
+4,128
| +2% | +$312K | 0.49% | 61 |
|
|
2017
Q2 | $13.8M | Buy |
184,893
+1,256
| +0.7% | +$89K | 0.47% | 62 |
|
|
2017
Q1 | $12.2M | Sell |
183,637
-2,321
| -1% | -$155K | 0.43% | 66 |
|
|
2016
Q4 | $12.1M | Sell |
185,958
-22,413
| -11% | -$1.45M | 0.45% | 63 |
|
|
2016
Q3 | $14.7M | Buy |
208,371
+9,177
| +5% | +$669K | 0.78% | 38 |
|
|
2016
Q2 | $14.7M | Buy |
199,194
+11,848
| +6% | +$819K | 0.79% | 34 |
|
|
2016
Q1 | $12.2M | Buy |
187,346
+17,724
| +10% | +$1.21M | 0.64% | 49 |
|
|
2015
Q4 | $13.1M | Buy |
169,622
+79,668
| +89% | +$6.33M | 0.69% | 44 |
|
|
2015
Q3 | $7.41M | Buy |
89,954
+14,265
| +19% | +$1.27M | 0.42% | 66 |
|
|
2015
Q2 | $6.67M | Sell |
75,689
-1,100
| -1% | -$101K | 0.35% | 76 |
|
|
2015
Q1 | $6.79M | Sell |
76,789
-216
| -0.3% | -$19.2K | 0.34% | 78 |
|
|
2014
Q4 | $6.39M | Sell |
77,005
-2,042
| -3% | -$169K | 0.33% | 78 |
|
|
2014
Q3 | $6.67M | Sell |
79,047
-558
| -0.7% | -$45.1K | 0.35% | 72 |
|
|
2014
Q2 | $6.46M | Buy |
79,605
+10,548
| +15% | +$830K | 0.34% | 73 |
|
|
2014
Q1 | $5.26M | Sell |
69,057
-10,045
| -13% | -$732K | 0.31% | 76 |
|
|
2013
Q4 | $5.7M | Buy |
79,102
+7,672
| +11% | +$533K | 0.33% | 75 |
|
|
2013
Q3 | $4.91M | Buy |
71,430
+5,714
| +9% | +$378K | 0.31% | 75 |
|
|
2013
Q2 | $4.16M | Buy |
+65,716
| New | +$4.28M | 0.27% | 77 |
|
Other funds holding NVS
People's United Financial's NVS Position: Q1 2022 in Review
People's United Financial reduced its Novartis (NVS) stake by 3.7% in Q1 2022, selling an estimated $116K and leaving 35,064 shares worth $3.08M. The position accounts for 0.09% of the portfolio, ranked #172.
People's United Financial first reported a position in NVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $14.7M in Q3 2016. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.
- People's United Financial held 35,064 shares of Novartis worth $3.08M as of Q1 2022.
- People's United Financial sold 1,341 Novartis shares in Q1 2022, an estimated $116K.
- Novartis made up 0.09% of People's United Financial's portfolio in Q1 2022, its #172 holding.
- People's United Financial first reported a position in Novartis in Q2 2013 and has held it in 36 quarters since.
- People's United Financial's Novartis position peaked at $14.7M in Q3 2016.
- 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.
Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.